Catyalyst Pharmaceutical Partners (CPRX) Posts Q4 Loss of 10c/Share
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.39 +0.03%
Revenue Growth %: +5.9%
Financial Fact:
General and administrative: 1.42M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +5.9%
Financial Fact:
General and administrative: 1.42M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q4 EPS of ($0.10), $0.04 worse than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Goldman "broadly" raises estimates for LTL and truckload stocks
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
